FR2873386B1 - Composition vaccinale contre le rhodococcus equi - Google Patents

Composition vaccinale contre le rhodococcus equi

Info

Publication number
FR2873386B1
FR2873386B1 FR0408136A FR0408136A FR2873386B1 FR 2873386 B1 FR2873386 B1 FR 2873386B1 FR 0408136 A FR0408136 A FR 0408136A FR 0408136 A FR0408136 A FR 0408136A FR 2873386 B1 FR2873386 B1 FR 2873386B1
Authority
FR
France
Prior art keywords
vaccine composition
composition against
rhodococcus equi
against rhodococcus
equi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0408136A
Other languages
English (en)
Other versions
FR2873386A1 (fr
Inventor
Said Taouji
Julien Cauchard
Jean Jacques Ballet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agence Francaise de Securite Sanitaire des Aliments (AFSSA)
Original Assignee
Agence Francaise de Securite Sanitaire des Aliments (AFSSA)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence Francaise de Securite Sanitaire des Aliments (AFSSA) filed Critical Agence Francaise de Securite Sanitaire des Aliments (AFSSA)
Priority to FR0408136A priority Critical patent/FR2873386B1/fr
Priority to US11/572,293 priority patent/US8052978B2/en
Priority to CA002574516A priority patent/CA2574516A1/fr
Priority to PCT/FR2005/001793 priority patent/WO2006021643A1/fr
Priority to EP05788683A priority patent/EP1769065A1/fr
Publication of FR2873386A1 publication Critical patent/FR2873386A1/fr
Application granted granted Critical
Publication of FR2873386B1 publication Critical patent/FR2873386B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
FR0408136A 2004-07-22 2004-07-22 Composition vaccinale contre le rhodococcus equi Active FR2873386B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0408136A FR2873386B1 (fr) 2004-07-22 2004-07-22 Composition vaccinale contre le rhodococcus equi
US11/572,293 US8052978B2 (en) 2004-07-22 2005-07-12 Vaccine composition against Rhodococcus equi
CA002574516A CA2574516A1 (fr) 2004-07-22 2005-07-12 Composition vaccinale contre rhodococcus equi
PCT/FR2005/001793 WO2006021643A1 (fr) 2004-07-22 2005-07-12 Composition vaccinale contre rhodococcus equi
EP05788683A EP1769065A1 (fr) 2004-07-22 2005-07-12 Composition vaccinale contre rhodococcus equi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408136A FR2873386B1 (fr) 2004-07-22 2004-07-22 Composition vaccinale contre le rhodococcus equi

Publications (2)

Publication Number Publication Date
FR2873386A1 FR2873386A1 (fr) 2006-01-27
FR2873386B1 true FR2873386B1 (fr) 2011-01-14

Family

ID=34947030

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0408136A Active FR2873386B1 (fr) 2004-07-22 2004-07-22 Composition vaccinale contre le rhodococcus equi

Country Status (5)

Country Link
US (1) US8052978B2 (fr)
EP (1) EP1769065A1 (fr)
CA (1) CA2574516A1 (fr)
FR (1) FR2873386B1 (fr)
WO (1) WO2006021643A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0919733D0 (en) * 2009-11-11 2009-12-30 Univ Edinburgh Immune system modulating composition
IT201900014121A1 (it) 2019-08-06 2021-02-06 Univ Degli Studi Di Camerino Marinomonas ef1 e rhodococcus ef1 per la produzione di metaboliti secondari

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803070A (en) 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
WO1994015636A1 (fr) 1993-01-08 1994-07-21 Csl Limited Preparations de vaccins
CA2125426A1 (fr) * 1994-06-08 1995-12-09 University Of Guelph Sequence de gene de rhodococcus equi
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
ATE215385T1 (de) 1997-12-16 2002-04-15 Chiron Corp Verwendung von mikropartikeln mit submikron öl/wasser emulsionen
CA2330610A1 (fr) 1998-05-07 1999-11-11 Corixa Corporation Composition d'adjuvant et procedes d'utilisation de celle-ci
US6585973B1 (en) 1998-10-29 2003-07-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method for preparing solid phase conjugated vaccine
HUP0200302A2 (en) * 1999-02-18 2002-05-29 Rmf Dictagene Sa Malaria vaccine
KR20020012221A (ko) 1999-05-20 2002-02-15 파르마솔 게엠베하 체액성 및 세포성 면역 반응을 증진시키기 위한, 안정성과생체 적합성이 최적화된 애쥬반트
US20020058040A1 (en) * 1999-12-23 2002-05-16 Stephen Grimes Stable immunogenic composition for frozen storage
FR2825276B1 (fr) 2001-05-31 2004-11-26 Seppic Sa Adujvant d'immunite sous forme solide et vaccin le contenant
US20040038303A1 (en) 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles

Also Published As

Publication number Publication date
CA2574516A1 (fr) 2006-03-02
EP1769065A1 (fr) 2007-04-04
US20080008726A1 (en) 2008-01-10
WO2006021643A1 (fr) 2006-03-02
FR2873386A1 (fr) 2006-01-27
US8052978B2 (en) 2011-11-08

Similar Documents

Publication Publication Date Title
FR22C1008I2 (fr) Composition immunogène
IL192084A0 (en) Vaccine
GB0607088D0 (en) Vaccine
BRPI0809573A2 (pt) composição, e, método
ZA200709518B (en) Vaccine composition
BRPI0814167A2 (pt) Composição, e, método
BRPI0807903A2 (pt) Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.
EP2075005A4 (fr) Vaccin de salk (ipv ) et contre la diphtérie, la coqueluche et le tétanos (dpt)
ZA200709207B (en) Vaccine
GB0617602D0 (en) Vaccine
GB0516944D0 (en) Vaccine
FR2873386B1 (fr) Composition vaccinale contre le rhodococcus equi
GB0810662D0 (en) Vaccine
ZA200709210B (en) Vaccine
GB0526412D0 (en) Vaccine
GB0521164D0 (en) Vaccine
IL186591A0 (en) Vaccine
GB0526232D0 (en) Vaccine
GB0513189D0 (en) Vaccine
IL186586A0 (en) Vaccine
GB0513194D0 (en) Vaccine
GB0513191D0 (en) Vaccine
GB0503000D0 (en) Anti-atheroma vaccine
GB0502569D0 (en) Vaccine composition
AU2006905910A0 (en) Vaccine

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20